21 - 40 of about 66
English: Ohara M, Ohara K, Kumai T, Ohkuri T, Nagato T, Hirata-Nozaki Y, Kosaka A, Nagata M, Hayashi R, Harabuchi S, Yajima Y, Oikawa K, Harabuchi Y, Sumi Y, Furukawa H, Kobayashi H., Phosphorylated vimentin as an immunotherapeutic target against metastatic colorectal cancer. , Cancer Immunol Immunother. , vol.69 (6) (p.989 - 999) , 2020 , (IF:6.968)
English: Harabuchi S, Kosaka A, Yajima Y, Nagata M, Hayashi R, Kumai T, Ohara K, Nagato T, Oikawa K, Ohara M, Harabuchi Y, Ohkuri T, Kobayashi H., Intratumoral STING activations overcome negative impact of cisplatin on antitumor immunity by inflaming tumor microenvironment in squamous cell carcinoma. , Biochem Biophys Res Commun. , vol.522 (2) (p.408 - 414) , 2020 , (IF:3.575)
English: Hirata-Nozaki Y, Ohkuri T, Ohara K, Kumai T, Nagata M, Harabuchi S, Kosaka A, Nagato T, Ishibashi K, Oikawa K, Aoki N, Ohara M, Harabuchi Y, Uno Y, Takei H, Celis E, Kobayashi H., PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma. , J Transl Med. , vol.17 (1) (p.1430 - ) , 2019 , (IF:5.531)
English: Nagato T, Ueda S, Takahara M, Kishibe K, Komabayashi Y, Kumai T, Ohara K, Hirata-Nozaki Y, Harabuchi S, Hayashi R, Ohkuri T, Bernasconi M, Nadal D, Kobayashi H, Harabuchi Y., Cyclin-dependent kinase 1 and survivin as potential therapeutic targets against nasal natural killer/T-cell lymphoma. , Lab Invest. , vol.99 (5) (p.612 - 624) , 2019 , (IF:5.662)
English: Kenzo Ohara, Takayuki Ohkuri, Takumi Kumai, Toshihiro Nagato, Yui Hirata-Nozaki, Kei Ishibashi, Akemi Kosaka, Marino Nagata, Shohei Harabuchi, Mizuho Ohara, Kensuke Oikawa, Naoko Aoki, Yasuaki Harabuchi, Esteban Celis, and Hiroya Kobayashi. , Targeting phosphorylated p53 to elicit tumor-reactive T helper responses against head and neck squamous cell carcinoma , Oncoimmunology , vol.7 (9) (p.e1466771. - ) , 2018 , (IF:7.719)
English: Sultan H, Kumai T, Fesenkova VI, Fan AE, Wu J, Cho HI, Kobayashi H, Harabuchi Y, Celis E., Sustained persistence of IL2 signaling enhances the antitumor effect of peptide vaccines through T-cell expansion and preventing PD-1 inhibition. , Cancer Immunol Res. , vol.6 (5) (p.617 - 627) , 2018 , (IF:9.188)
English: Ohkuri T, Kosaka A, Nagato T, Kobayashi H., Effects of STING stimulation on macrophages: STING agonists polarize into "classically" or "alternatively" activated macrophages? , Hum Vaccin Immunother , vol.14 (2) (p.285 - 287) , 2018 , (IF:2.157)
English: Uehara J, Ohkuri T, Kosaka A, Ishibashi K, Hirata Y, Ohara K, Nagato T, Oikawa K, Aoki N, Harabuchi Y, Ishida-Yamamoto A, Kobayashi H. , Intratumoral injection of IFN-β induces chemokine production in melanoma and augments the therapeutic efficacy of anti-PD-L1 mAb. , Biochem Biophys Res Commun. , vol.490 (2) (p.521 - 527) , 2017 , (IF:2.466)
English: Kumai T, Kobayashi H, Harabuchi Y, Celis E., Peptide vaccines in cancer-old concept revisited. , Curr Opin Immunol. , vol.45 (p.1 - 7) , 2017 , (IF:8.384)
English: Azuma H, Yoshida Y, Takahashi H, Ishibazawa E, Kobayashi H, Sakai H, Takahashi D, Fujihara M., Liposomal microparticle injection can induce myeloid-derived suppressor cells (MDSC)-like cells in vivo. , Immunopharmacol Immunotoxicol , vol.5 (p.1 - 8) , 2017 , (IF:1.617)
English: Kumai T, Lee S, Cho HI, Sultan H, Kobayashi H, Harabuchi Y, Celis E., Optimization of Peptide Vaccines to Induce Robust Antitumor CD4 T-cell Responses. , Cancer Immunol Res. , vol.5 (1) (p.72 - 83) , 2017 , (IF:8.284)
English: Ohkuri T, Kosaka A, Ishibashi K, Kumai T, Hirata Y, Ohara K, Nagato T, Oikawa K, Aoki N, Harabuchi Y, Celis E, Kobayashi H., Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site. , Cancer Immunol Immunother. , vol.66 (6) (p.705 - 716) , 2017 , (IF:4.711)
English: Nagato T, Ohkuri T, Ohara K, Hirata Y, Kishibe K, Komabayashi Y, Ueda S, Takahara M, Kumai T, Ishibashi K, Kosaka A, Aoki N, Oikawa K, Uno Y, Akiyama N, Sado M, Takei H, Celis E, Harabuchi Y, Kobayashi H., Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy. , Cancer Immunol Immunother. , vol.66 (7) (p.877 - 890) , 2017 , (IF:4.711)
English: Oikawa K, Odero GL, Nafez S, Ge N, Zhang D, Kobayashi H, Sate K, Kimura S, Tateno M, Albensi BC., Visinin-Like Protein-3 Modulates the Interaction Between Cytochrome b (5) and NADH-Cytochrome b (5) Reductase in a Ca(2+)-Dependent Manner. , Cell Biochem Biophys. , vol.74 (4) (p.449 - 457) , 2016 , (IF:1.627)
English: Kumai T, Oikawa K, Aoki N, Kimura S, Harabuchi Y, Kobayashi H., Assessment of the change in cetuximab induced ADCC activity of NK cells by steroid. Kumai T, Oikawa K, Aoki N, Kimura S, Harabuchi Y, Kobayashi H. , Head & Neck , vol.38 (3) (p.410 - 416) , 2016 , (IF:3.006)
English: Ishibashi K, Kumai T, Ohkuri T, Kosaka A, Nagato T, Hirata Y, Ohara K, Oikawa K, Aoki N, Akiyama N, Sado M, Kitada M, Harabuchi Y, Celis E, Kobayashi H., Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy. , Oncoimmunology , vol.30 (5) (p.e1169356 - ) , 2016 , (IF:7.644)
English: Kumai T, Kobayashi H, Harabuchi Y., Novel targets for natural killer/T-cell lymphoma immunotherapy. , Immunotherapy , vol.8 (1) (p.45 - 55) , 2016 , (IF:2.070)
English: Shimouchi A, Yokota H, Ono S, Matsumoto C, Tamai T, Takumi H, Narayanan SP, Kimura S, Kobayashi H, Caldwell RB, Nagaoka T, Yoshida A., Neuroprotective effect of water-dispersible hesperetin in retinal ischemia reperfusion injury. , Jpn J Ophthalmol. , vol.60 (1) (p.51 - 61) , 2016 , (IF:1.676)
English: Ohtake J, Kaneumi S, Tanino M, Kishikawa T, Terada S, Sumida K, Masuko K, Ohno Y, Kita T, Iwabuchi S, Shinohara T, Tanino Y, Takemura T, Tanaka S, Kobayashi H, Kitamura H., Neuropeptide signaling through neurokinin-1 and neurokinin-2 receptors augments antigen presentation by human dendritic cells. , J Allergy Clin Immunol. , vol.136 (6) (p.1690 - 1694) , 2015 , (IF:11.476)
English: Kumai T, Ohkuri T, Nagato T, Matsuda Y, Oikawa K, Aoki N, Kimura S, Celis E, Harabuchi Y, Kobayashi H., Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma. , Sci Rep. , vol.5 (5) (p.16280 - ) , 2015 , (IF:5.578)
Copyright (C) 2012~ Asahikawa Medical University, All Rights Reserved.